Major US equity indices opened with mild bearish bias on Thursday, but struggled for a firm direction as investors remain cautious ahead of an important vote on Trump's health-care bill.
Today's House vote on the Trump-backed GOP plan to replace the Affordable Care Act would provide clarity on Trump's ability to deliver on his promises of tax cuts and infrastructure spending. A failure to pass the bill, or delaying it, would seriously dent investors' confidence and might trigger another round of sell-off in the equity markets.
Meanwhile, a fresh bout of selling pressure in oil markets, with WTI crude oil weakening back below $48.00/barrel mark, also collaborated to the mildly bearish trading sentiment around riskier-asset class - like equities.
On the economic data front, weekly initial jobless claims jumped by 15K to a two-month high level of 258K for the week ended March 17 and did little to boost investor sentiment.
At the time of writing, the Dow Jones Industrial Average was down around 15-points to 20645, while the broader S&P 500 Index lost 2-points to 2,345. Meanwhile, tech-heavy Nasdaq Composite Index slipped nearly 10-points to 5,810.
- R3 20824.67
- R2 20757.33
- R1 20718.67
- PP 20651.33
- S1 20612.67
- S2 20545.33
- S3 20506.67
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.